Lancet, NEJM Retract COVID-19 Research Papers After Concerns Raised On Data Integrity

Science: Two elite medical journals retract coronavirus papers over data integrity questions
“In the first big research scandal of the COVID-19 era, The Lancet and the New England Journal of Medicine (NEJM) [Thursday] retracted two high-profile papers after a company declined to make the underlying data for both available for an independent audit, following questions being raised about the research. The Lancet paper, which claimed an antimalarial drug touted by President Donald Trump for treatment of COVID-19 could cause serious harm without helping patients, had had a global impact, halting trials of one of the drugs by the World Health Organization (WHO) and others…” (Piller/Servick, 6/4).

Additional coverage of the studies’ retractions is available from Bloomberg, MedPage Today, New York Times, POLITICO, STAT, TIME, UPI, and VOA.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.